BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Du M, Yang S, Liu M, Liu J. COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms. Clin Res Hepatol Gastroenterol 2022;46:101793. [PMID: 34428501 DOI: 10.1016/j.clinre.2021.101793] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Liptak P, Nosakova L, Rosolanka R, Skladany L, Banovcin P. Acute-on-chronic liver failure in patients with severe acute respiratory syndrome coronavirus 2 infection. World J Hepatol 2023;15:41-51. [PMID: 36744167 DOI: 10.4254/wjh.v15.i1.41] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Farias JP, Codes L, Vinhaes D, Amorim AP, D'Oliveira RC, Farias AQ, Bittencourt PL. Impact of baseline abnormal liver enzymes in the outcome of COVID-19 infection. Transl Gastroenterol Hepatol 2023;8:5. [PMID: 36704646 DOI: 10.21037/tgh-22-41] [Reference Citation Analysis]
3 Özdemir Ö, Arsoy HEM. Commentary on COVID-19-induced liver injury in various age and risk groups. World J Virol 2023; 12(1): 44-52 [PMID: 36743662 DOI: 10.5501/wjv.v12.i1.44] [Reference Citation Analysis]
4 Naeem M, Bano N, Manzoor S, Ahmad A, Munawar N, Razak SIA, Lee TY, Devaraj S, Hazafa A. Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients. Biomolecules 2023;13. [PMID: 36671484 DOI: 10.3390/biom13010099] [Reference Citation Analysis]
5 Bouare N. Current management of liver diseases and the role of multidisciplinary approach. World J Hepatol 2022;14:1920-30. [PMID: 36483606 DOI: 10.4254/wjh.v14.i11.1920] [Reference Citation Analysis]
6 Lu JY, Ho SL, Buczek A, Fleysher R, Hou W, Chacko K, Duong TQ. Clinical predictors of recovery of COVID-19 associated-abnormal liver function test 2 months after hospital discharge. Sci Rep 2022;12:17972. [PMID: 36289394 DOI: 10.1038/s41598-022-22741-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Denızlı R, Sakcak B, Farisoğulları N, Peker MEM, Sınacı S, Kara Ö, Tanacan A, Tekın ÖM, Şahın D. The İmpact of Elevated Liver Enzymes and İntrahepatic Cholestasis of Pregnancy on the Course of COVID-19 in Pregnant Women. SN Compr Clin Med 2022;4:184. [DOI: 10.1007/s42399-022-01267-1] [Reference Citation Analysis]
8 Ghafoor S, Germann M, Jüngst C, Müllhaupt B, Reiner CS, Stocker D. Imaging features of COVID-19-associated secondary sclerosing cholangitis on magnetic resonance cholangiopancreatography: a retrospective analysis. Insights Imaging 2022;13:128. [PMID: 35939241 DOI: 10.1186/s13244-022-01266-9] [Reference Citation Analysis]
9 Restrepo-gutiérrez JC, Toro-montoya AI. Enfermedad hepatobiliar asociada a COVID-19. Hepatología 2022. [DOI: 10.52784/27112330.155] [Reference Citation Analysis]
10 Vollenberg R, Tepasse PR, Fobker M, Hüsing-Kabar A. Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 Patients. Nutrients 2022;14. [PMID: 35631143 DOI: 10.3390/nu14102007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kurakh AV, Hechko MM, Chopey IV. COVID-19 AND PRIMARY CARE: POSSIBILITIES FOR INCREASING POSITIVE OUTCOMES. Wiad Lek 2021;74:2659-2662. [DOI: 10.36740/wlek202110225] [Reference Citation Analysis]